Hebert Peter
Transactions
30
Companies
8
Filings
16
CIK
0001683771
Recent Transactions
- Disposition to Issuer
- Disposition to Issuer
- Exercise/Conversion
- Award
- Purchase
- Award
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Other
- Award
- Award
- Purchase
- Other
- Other
- Other
- Award
- Award
- Award
Nonqualified Stock Option (Right to Buy)
2019-05-21+12,000→ 12,000 total - Award
Nonqualified Stock Option (Right to Buy)
2018-05-21+12,000→ 12,000 total - Award
- Conversion
- Conversion
- Conversion
- Conversion
- Conversion
- Conversion
- Conversion
- Conversion
- Purchase
Companies
8- $AEVA
Aeva Technologies, Inc.
10% Owner
- $EIKN
Eikon Therapeutics, Inc.
10% Owner
- $MRAM
EVERSPIN TECHNOLOGIES INC.
Director, 10% Owner
Latch, Inc.
10% Owner
Lux Health Tech Acquisition Corp.
10% Owner
Matterport, Inc./DE
Director
- $RXRX
RECURSION PHARMACEUTICALS, INC.
Former 10% Owner
Science 37 Holdings, Inc.
10% Owner
Recent Filings
16- 4
Hebert Peter
Mar 3, 2025
- 4
Hebert Peter
Jun 12, 2024
- 4
Hebert Peter
Aug 18, 2023
- 4
Hebert Peter
Jun 29, 2023
- 4/A
Hebert Peter
Jun 29, 2023
- 4/A
Hebert Peter
Jun 29, 2023
- 4
Hebert Peter
Jun 14, 2023
- 4
Lux Ventures IV, L.P.
Aug 9, 2022
- 4
Hebert Peter
Jul 11, 2022
- 4
Hebert Peter
Feb 28, 2022
- 4
Lux Ventures III, L.P.
Jan 21, 2022
- 4
Hebert Peter
Jan 21, 2022
- 4
Lux Ventures IV, L.P.
Sep 10, 2021
- 4
Hebert Peter
May 20, 2020
- 4
Hebert Peter
May 22, 2019
- 4
Hebert Peter
May 22, 2018
Address
920 BROADWAY, 11TH FLOOR
NEW YORK, NY, 10010